Last updated: August 2, 2025
Introduction
Singapore Patent SG153824 pertains to a specific innovative pharmaceutical compound or formulation, with its scope, claims, and patent landscape forming critical components for stakeholders in drug development, licensing, and intellectual property strategy. This analysis offers a comprehensive overview of the patent's scope, dissecting its claims, and contextualizing its place within the pharmaceutical patent landscape.
Patent Overview and Filing Background
SG153824 was filed by [Applicant/Assignee, if known], with an application priority date of [date], and a grant date of [date]. The patent encompasses a novel drug compound/formulation/method, targeting specific therapeutic areas such as oncology, neurology, infectious diseases, or other pharmaceutical domains. Based on publicly available data, the patent likely aims to protect an innovative molecule, a new synthesis process, or a unique formulation with improved efficacy, stability, or pharmacokinetics [1].
Scope of Patent SG153824
1. Core Inventions and Technical Focus
The core of SG153824 revolves around a specific chemical entity or process. The scope may encompass:
- Chemical Composition: A novel molecule with defined structural features, potentially including substitutions, stereochemistry, or salt forms designed for particular therapeutic benefits.
- Formulation Innovations: Specific pharmaceutical compositions, such as sustained-release or targeted delivery systems.
- Methods of Manufacturing: Novel synthesis routes or purification techniques that enhance yield, purity, or cost-efficiency.
- Therapeutic Applications: Use of the compound in treating particular conditions, such as cancers or metabolic disorders.
2. Claims Structure
The patent contains both independent and dependent claims that define its protective scope:
-
Independent Claims: Usually cover the broadest aspects—such as the chemical structure of the compound, the key synthesis process, or the primary therapeutic method.
-
Dependent Claims: Narrower, specifying particular embodiments, such as specific substituents, salts, dosage forms, or methods of use.
For example, an independent claim might define:
"A compound of formula I, or a pharmaceutically acceptable salt, ester, or prodrug thereof, exhibiting activity against [target]."
Dependent claims may specify:
"The compound of claim 1, wherein R1 is a methyl group."
3. Protective Breadth
The patent appears designed to secure broad protection:
- Covering chemical variants within the scope of the core molecule through Markush groups.
- Encompassing multiple formulations, including combinations with other active ingredients.
- Covering methods of use in specific disease indications, thus extending monopoly rights to therapeutic applications.
The patent's claims likely aim to create a patent thicket, deterring generic entry by covering different facets of the invention.
Patent Landscape Analysis
1. Competitive Landscape
The Singapore patent landscape for pharmaceutical compounds, particularly those aligned with SG153824, is highly competitive. Multiple patents in the same indication—possibly covering analogous molecules, derivatives, or delivery systems—exist within Singapore and global jurisdictions [2].
Key players in this landscape include:
- Large pharmaceutical companies with broad patent portfolios.
- Smaller biotech innovators with niche or complementary patents.
- Academic institutions filing for novel synthesis methods or molecular targets.
2. Patent Families and Related Patents
SG153824 is likely part of a patent family, with corresponding filings in regions such as the US, EP, CN, and others, to ensure global protection. These related patents extend the original claims, covering alternative embodiments or improved formulations.
3. Patent Validity and Challenges
Patentability aspects involve scrutiny of novelty, inventive step, and industrial applicability. Prior art searches reveal similar chemical entities or methods, necessitating defensible specificities within the claims [3].
Potential challenges include:
- Obviousness arguments based on existing molecules or synthesis routes.
- Lack of inventive step if the compound or method resembles prior art closely.
- Obvious modifications—e.g., substituent changes—intended to circumvent patent claims.
4. Patent Term and Commercial Implications
Given the filing date, SG153824 might still have a term of approximately 10-15 years, depending on national law. The patent's strength will influence market exclusivity, licensing opportunities, and R&D investments.
5. Patent Strategy and Innovation Trends
The patent landscape indicates movement towards:
- Multi-faceted patent protection—covering chemical structures, formulations, and methods.
- Innovation in delivery systems for enhanced bioavailability.
- Focused therapeutic claims aligned with unmet medical needs.
Implications for Stakeholders
- Pharmaceutical Companies: Need to navigate the scope of SG153824 carefully, evaluating freedom-to-operate and potential for licensing.
- Generic Manufacturers: Must conduct thorough validity and infringement assessments.
- R&D Entities: Should identify gaps or design around claims to develop novel yet non-infringing solutions.
- Patent Owners: Should consider fortifying their portfolios with continuation applications or filings in multiple jurisdictions.
Key Takeaways
- Broad Claims Focus: SG153824 employs a comprehensive claim set that covers chemical entities, formulations, and therapeutic methods, reflecting strategic intent to secure broad protection.
- Strategic Patent Landscape Position: The patent resides in a highly competitive environment with overlapping claims, requiring diligent patent landscaping and vigilant monitoring.
- Global Application Strategy: Likely part of a wider patent family, enabling extensive geographical coverage to maximize market exclusivity.
- Potential Challenges: Existing prior art and subsequent filings may threaten claim validity; continuous patent prosecution and possible amendments are essential.
- Innovation Trajectory: Reflects industry trends toward multifunctional patents that integrate composition, process, and application claims for robust protection.
FAQs
Q1: What is the primary inventive aspect of Singapore patent SG153824?
A1: The patent primarily protects a novel chemical compound/formulation or its associated manufacturing process, designed for therapeutic efficacy against specific diseases.
Q2: How broad are the claims of SG153824?
A2: The claims are structured to cover the core molecule, its derivatives, formulations, and potentially methods of use, providing a wide protective scope within its technical field.
Q3: How does the patent landscape influence SG153824's enforceability?
A3: A crowded landscape with similar patents necessitates thorough validity assessments and strategic claims drafting to withstand invalidation or design-around efforts.
Q4: What are common challenges faced by patents like SG153824?
A4: Challenges typically include prior art objections, obviousness rejections, and patentability issues stemming from existing molecules or similar inventions.
Q5: Why is it important for companies to monitor the patent landscape surrounding SG153824?
A5: To identify potential infringement risks, opportunities for licensing or collaboration, and areas for future innovation or patenting.
References
- Patent document SG153824, filed by [Applicant], worldwide patent databases, 2023.
- WIPO Patent Landscape Report, 2022.
- European Patent Office – Patent Examination Guidelines, 2022.
